We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Revises Policy for Certificates of Confidentiality
FDA Revises Policy for Certificates of Confidentiality
The FDA on Friday issued a new draft guidance that would formalize its current process for issuing discretionary Certificates of Confidentiality for commercial sponsors that seek to prohibit disclosure of identifiable information about a research participant.